By
Aaron Nicodemus2022-12-21T18:51:00
A Texas-based IT firm and its former chief financial officer settled charges brought by the Securities and Exchange Commission (SEC) alleging failure to properly account for and record liabilities related to a shareholder lawsuit.
Exela Technologies and former CFO James Reynolds agreed to pay $175,000 and $10,000, respectively, to settle claims they violated reporting, controls, and recordkeeping provisions of federal securities law, the SEC said Monday.
According to the agency’s order, Exela failed to properly account for and report liabilities when it was sued by minority shareholders who dissented from a 2017 merger. From 2017-19, the company failed to accrue for any payment it would have to make to those shareholders, despite disclosing the shareholders’ claim in SEC filings.
2025-11-07T22:18:00Z By Adrianne Appel
First Trust Portfolios has been fined $10 million by FINRA for allegedly providing excessive meals, gifts, and other incentives to broker-dealers.
2025-11-06T19:06:00Z By Jaclyn Jaeger
Compliance Week recently interviewed Charles Duross, former Chief of the DOJ’s Fraud Section’s FCPA Unit, to talk about the Department of Justice’s recently revised monitorship policy.
2025-11-06T19:01:00Z By Adrianne Appel
Four U.S. citizens were arrested in California Wednesday in connection with a massive, $346 million international credit card fraud scheme based in Germany, in which compliance officers were allegedly complicit, according to the DOJ.
2025-11-05T18:35:00Z By Oscar Gonzalez
Approximately $9 billion of potential shadow-banking flows tied to Iranian networks in 2024, according to a new analysis from FinCEN. The report highlights how illicit funds are making their way through financial institutions as they meet the requirements of the Bank Secrecy Act (BSA).
2025-10-31T18:52:00Z By Oscar Gonzalez
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
2025-10-30T19:59:00Z By Oscar Gonzalez
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
Site powered by Webvision Cloud